Correction Notice: Article DOI Updated

Credibility

Interest

Key Takeaway

This article corrects a previously published paper’s digital identifier (DOI), so patients should use the updated DOI when looking up the corrected study to ensure they find the right information.

What They Found

The published notice fixes the DOI (a unique web address for a journal article) so readers can reliably find the correct study. A DOI is like a permanent library call number on the internet—if it’s wrong, you can’t find the book. This correction does not add new medical results or change the study’s data; it only fixes the article’s reference information. Because this is a publishing correction, there are no new treatment recommendations or symptom findings. The corrected DOI helps patients, caregivers, and doctors access the original paper accurately if they need to read or share it.

Who Should Care and Why

MS patients and caregivers who look up medical studies should care because an incorrect DOI can lead to wasted time or finding the wrong article—like trying to call someone with the wrong phone number. Health professionals and researchers also care because they rely on correct citations to build safe treatment advice. If you are researching MS treatments, symptom management, or clinical trials, the corrected DOI helps ensure you read the exact study referenced. Caregivers who keep records or share resources will find it easier to point others to the right source. In short, anyone who wants to read or verify the original article will benefit from the fix.

Important Considerations

This correction only fixes the article’s DOI and does not change the scientific results, methods, or conclusions of the original study. If you need clinical advice for MS, rely on your healthcare provider—this correction alone does not change care. When searching for research, double-check DOI links or use trusted databases (like PubMed) to avoid mistakenly reading the wrong paper.

Categories:

MS Genetics Early Research MS Progression

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like iScience often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News